Loading...

新闻列表

Wang Ben's team at Zhejiang University developed fluorine-containing polymer assembly drugs to achieve chemotherapeutic-immune cascade cancer therapy

2023-04-23


Wang Ben's team at Zhejiang University developed fluorine-containing polymer assembly drugs to achieve chemotherapeutic-immune cascade cancer therapy

Recently, Wang's research group from the Institute of Translational Medicine of Zhejiang University/The Second Affiliated Hospital of Zhejiang University Medical College published a paper titled: Chemoimmunological Cascade Cancer Therapy Using <s:1> Assembly Nanomedicine.

This study reports a therapeutic strategy for reprogramming chemotherapy and immune cells by assembling drugs from co-carrying drug-gene fluorine-containing polymers. The polymeric assembly drug loaded with adriamycin induced immunogenic death of tumor cells, and reversed depletion of CD8+ T cells through small interfering RNA (siRNA), effectively exerting its anti-tumor immune effect. In both breast cancer and melanoma mouse models, polymer-assembled drugs showed enhanced effects on cancer immunotherapy and significantly inhibited tumor growth and metastasis.


上一页: 浙江大学王本团队开发含氟高分子组装药物,实现化药-免疫级联癌症治疗

下一页: FDA批准首个可重复给药基因疗法,每年63万美元,治疗“最痛苦疾病”